You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ipf

Showing 1 - 25 of 558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
May 15, 2023

Idiopathic Pulmonary Fibrosis Trial (Axatilimab, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Nov 9, 2023

Idiopathic Pulmonary Fibrosis Trial in Beijing (SC1011, Placebo comparator)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 4, 2023

Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • nalbuphine ER
  • Placebo
  • (no location specified)
Jul 19, 2023

Idiopathic Pulmonary Fibrosis Trial (Ifetroban Sodium, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ifetroban Sodium
  • Placebo
  • (no location specified)
Jan 25, 2023

All-Case Surveillance of Ofev in Patients With IPF in Japan

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Multiple Locations, Japan
    (unnamed)
Jan 23, 2023

Idiopathic Pulmonary Fibrosis Trial in London (LTI-03, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • London, United Kingdom
    Study Site
Jul 18, 2023

Idiopathic Pulmonary Fibrosis Trial in Beijing, Shanghai (REGEND001, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • REGEND001
  • Placebo
  • Beijing, Beijing, China
  • +2 more
Oct 7, 2023

Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)

Recruiting
  • Interstitial Lung Diseases
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Apr 13, 2023

Idiopathic Pulmonary Fibrosis Trial in Palo Alto (PLN-74809, Knottin tracer)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Palo Alto, California
    Stanford Medical Center
Nov 15, 2022

Idiopathic Pulmonary Fibrosis, IPF Trial in Izmir (Inspiratory Muscle Training (IMT), Sham IMT)

Completed
  • Idiopathic Pulmonary Fibrosis
  • IPF
  • Inspiratory Muscle Training (IMT)
  • Sham IMT
  • Izmir, Balcova, Turkey
    Dokuz Eylul University
Nov 6, 2022

IPF Trial in China (PMG1015, PMG1015 )

Recruiting
  • IPF
  • Beijing, Beijing, China
  • +5 more
May 31, 2023

Idiopathic Pulmonary Fibrosis (IPF) Trial in China, United States (INS018_055, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Los Angeles, California
  • +9 more
Jul 6, 2023

Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperpolarized Xe129)

Withdrawn
  • Idiopathic Pulmonary Fibrosis
  • Hypersensitivity Pneumonitis
  • Hyperpolarized Xe129
  • (no location specified)
Sep 6, 2022

Idiopathic Pulmonary Fibrosis Trial in Boston (PLN-74809, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 14, 2022

Idiopathic Pulmonary Fibrosis Trial (TDI01 suspension)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • TDI01 suspension
  • (no location specified)
Oct 30, 2023

Idiopathic Pulmonary Fibrosis Trial in Zhengzhou (Jin-shui Huan-xian granule, Jin-shui Huan-xian granule )

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Jin-shui Huan-xian granule
  • Jin-shui Huan-xian granule placebo
  • Zhengzhou, China
    the First Affiliated Hospital of Henan University of Chinese Med
Aug 17, 2022

Reliability and Validity of iOS in IPF

Completed
  • Idiopathic Pulmonary Fibrosis
    • London, Gb-lnd, United Kingdom
      Royal Brompton and Harefield hospitals
    May 4, 2022

    Idiopathic Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastro Esophageal Reflux Trial in Tucson (Positive Airway Pressure)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • +2 more
    • Positive Airway Pressure
    • Tucson, Arizona
      University of Arizona
    Sep 15, 2022

    Idiopathic Pulmonary Fibrosis Trial in Stanford (Artesunate Oral Product)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Artesunate Oral Product
    • Stanford, California
      Stanford University
    Aug 4, 2023

    Idiopathic Pulmonary Fibrosis Trial (BBT-877, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • (no location specified)
    Jul 29, 2022

    Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, Shanghai (REGEND001 Autologous Therapy Product)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • REGEND001 Autologous Therapy Product
    • Beijing, Beijing, China
    • +2 more
    Dec 19, 2022

    Idiopathic Pulmonary Fibrosis, IPF Trial in Hershey (tipelukast, Placebo)

    Completed
    • Idiopathic Pulmonary Fibrosis
    • IPF
    • Hershey, Pennsylvania
      Penn State University College of Medicine, Milton S. Hershey Med
    Apr 25, 2022

    Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

    Active, not recruiting
    • Pulmonary Fibrosis
      • Pittsburgh, Pennsylvania
        University of Pittsburgh
      Dec 13, 2022

      Idiopathic Pulmonary Fibrosis Trial in Shanghai (Human umbilical cord mesenchymal stem cell injection)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Human umbilical cord mesenchymal stem cell injection
      • Shanghai, Shanghai, China
        Shanghai Sixth People's Hospital
      Jul 29, 2022